Targeting eosinophils in allergy, inflammation and beyond. Fulkerson PC, Rothenberg ME Nature reviews. Drug discovery, 2013 Feb, Volume 12, Issue 2, p.117-29, (2013)
Eosinophils in infection and intestinal immunity. Hogan SP, Waddell A, Fulkerson PC Current opinion in gastroenterology, 2013 Jan, Volume 29, Issue 1, p.7-14, (2013)
Novel targeted therapies for eosinophilic disorders. Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J, Prussin C, Renzi P, Rothenberg ME, Roufosse F, Simon D, et al. The Journal of allergy and clinical immunology, 2012 Sep, Volume 130, Issue 3, p.563-71, (2012)
Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo. Wen T, Besse JA, Mingler MK, Fulkerson PC, Rothenberg ME Proceedings of the National Academy of Sciences of the United States of America, 2013 Apr 9, Volume 110, Issue 15, p.6067-72, (2013)
MiR-223 deficiency increases eosinophil progenitor proliferation. Lu TX, Lim E-J, Besse JA, Itskovich S, Plassard AJ, Fulkerson PC, Aronow BJ, Rothenberg ME Journal of immunology (Baltimore, Md. : 1950), 2013 Feb 15, Volume 190, Issue 4, p.1576-82, (2013)